These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 19787772

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.
    Ozers MS, Marks BD, Gowda K, Kupcho KR, Ervin KM, De Rosier T, Qadir N, Eliason HC, Riddle SM, Shekhani MS.
    Biochemistry; 2007 Jan 23; 46(3):683-95. PubMed ID: 17223690
    [Abstract] [Full Text] [Related]

  • 3. Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors.
    Urushibara M, Ishioka J, Hyochi N, Kihara K, Hara S, Singh P, Isaacs JT, Kageyama Y.
    Prostate; 2007 Jun 01; 67(8):799-807. PubMed ID: 17373727
    [Abstract] [Full Text] [Related]

  • 4. A novel steroidal antiandrogen targeting wild type and mutant androgen receptors.
    Andrieu T, Bertolini R, Nichols SE, Setoud R, Frey FJ, Baker ME, Frey BM.
    Biochem Pharmacol; 2011 Dec 01; 82(11):1651-62. PubMed ID: 21907706
    [Abstract] [Full Text] [Related]

  • 5. A Molecular Modeling Study of the Hydroxyflutamide Resistance Mechanism Induced by Androgen Receptor Mutations.
    Liu HL, Zhong HY, Song TQ, Li JZ.
    Int J Mol Sci; 2017 Aug 23; 18(9):. PubMed ID: 28832499
    [Abstract] [Full Text] [Related]

  • 6. Design and synthesis of androgen receptor antagonists with bulky side chains for overcoming antiandrogen resistance.
    Zhou J, Geng G, Shi Q, Sauriol F, Wu JH.
    J Med Chem; 2009 Sep 10; 52(17):5546-50. PubMed ID: 19725582
    [Abstract] [Full Text] [Related]

  • 7. Learning from estrogen receptor antagonism: structure-based identification of novel antiandrogens effective against multiple clinically relevant androgen receptor mutants.
    Liu B, Geng G, Lin R, Ren C, Wu JH.
    Chem Biol Drug Des; 2012 Mar 10; 79(3):300-12. PubMed ID: 22151347
    [Abstract] [Full Text] [Related]

  • 8. Suppression of mutant androgen receptors by flutamide.
    Ishioka J, Hara S, Isaacs JT, Tomura A, Nishikawa K, Kageyama Y.
    Int J Urol; 2009 May 10; 16(5):516-21. PubMed ID: 19389135
    [Abstract] [Full Text] [Related]

  • 9. Computationally identified novel diphenyl- and phenylpyridine androgen receptor antagonist structures.
    Söderholm AA, Viiliäinen J, Lehtovuori PT, Eskelinen H, Roell D, Baniahmad A, Nyrönen TH.
    J Chem Inf Model; 2008 Sep 10; 48(9):1882-90. PubMed ID: 18712859
    [Abstract] [Full Text] [Related]

  • 10. Antiandrogens prevent stable DNA-binding of the androgen receptor.
    Farla P, Hersmus R, Trapman J, Houtsmuller AB.
    J Cell Sci; 2005 Sep 15; 118(Pt 18):4187-98. PubMed ID: 16141232
    [Abstract] [Full Text] [Related]

  • 11. Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.
    Elhaji YA, Stoica I, Dennis S, Purisima EO, Lumbroso R, Beitel LK, Trifiro MA.
    Hum Mol Genet; 2006 Mar 15; 15(6):921-31. PubMed ID: 16449235
    [Abstract] [Full Text] [Related]

  • 12. Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
    Hara T, Miyazaki J, Araki H, Yamaoka M, Kanzaki N, Kusaka M, Miyamoto M.
    Cancer Res; 2003 Jan 01; 63(1):149-53. PubMed ID: 12517791
    [Abstract] [Full Text] [Related]

  • 13. Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR).
    Berrevoets CA, Umar A, Trapman J, Brinkmann AO.
    Biochem J; 2004 May 01; 379(Pt 3):731-8. PubMed ID: 14744261
    [Abstract] [Full Text] [Related]

  • 14. 4-(Anilino)pyrrole-2-carboxamides: Novel non-steroidal/non-anilide type androgen antagonists effective upon human prostate tumor LNCaP cells with mutated nuclear androgen receptor.
    Wakabayashi K, Imai K, Miyachi H, Hashimoto Y, Tanatani A.
    Bioorg Med Chem; 2008 Jul 15; 16(14):6799-812. PubMed ID: 18571420
    [Abstract] [Full Text] [Related]

  • 15. Molecular basis of agonicity and antagonicity in the androgen receptor studied by molecular dynamics simulations.
    Bisson WH, Abagyan R, Cavasotto CN.
    J Mol Graph Model; 2008 Nov 15; 27(4):452-8. PubMed ID: 18805032
    [Abstract] [Full Text] [Related]

  • 16. Design and synthesis of androgen receptor full antagonists bearing a p-carborane cage: promising ligands for anti-androgen withdrawal syndrome.
    Goto T, Ohta K, Fujii S, Ohta S, Endo Y.
    J Med Chem; 2010 Jul 08; 53(13):4917-26. PubMed ID: 20521823
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility.
    Marcelli M, Stenoien DL, Szafran AT, Simeoni S, Agoulnik IU, Weigel NL, Moran T, Mikic I, Price JH, Mancini MA.
    J Cell Biochem; 2006 Jul 01; 98(4):770-88. PubMed ID: 16440331
    [Abstract] [Full Text] [Related]

  • 19. Functional characterization of mutant androgen receptors from androgen-independent prostate cancer.
    Fenton MA, Shuster TD, Fertig AM, Taplin ME, Kolvenbag G, Bubley GJ, Balk SP.
    Clin Cancer Res; 1997 Aug 01; 3(8):1383-8. PubMed ID: 9815822
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.